Literature DB >> 26348738

Probing Our Moral Values in Health Care: The Pricing of Specialty Drugs.

Uwe Reinhardt1.   

Abstract

Mesh：

Year:  2015        PMID： 26348738     DOI： 10.1001/jama.2015.9593

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

Review 1.  Cholesterol Management in the Era of PCSK9 Inhibitors.

Authors:  Anna Svatikova; Stephen L Kopecky
Journal:  Curr Cardiol Rep       Date:  2017-09       Impact factor: 2.931

2.  Pharmaceutical pricing conundrum: time to get rid of it?

Authors:  Livio Garattini; Anna Padula
Journal:  Eur J Health Econ       Date:  2018-11

Review 3.  A systematic review of moral reasons on orphan drug reimbursement.

Authors:  Bettina M Zimmermann; Johanna Eichinger; Matthias R Baumgartner
Journal:  Orphanet J Rare Dis       Date:  2021-06-30       Impact factor: 4.123

Review 4.  Addressing the challenge of high-priced prescription drugs in the era of precision medicine: A systematic review of drug life cycles, therapeutic drug markets and regulatory frameworks.

Authors:  Toon van der Gronde; Carin A Uyl-de Groot; Toine Pieters
Journal:  PLoS One       Date:  2017-08-16       Impact factor: 3.240

5.  Precision medicine and monoclonal antibodies: breach of promise?

Authors:  Livio Garattini; Anna Padula
Journal:  Croat Med J       Date:  2019-06-13       Impact factor: 1.351
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.